Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
552.20Today’s High
585.0052W low
263.6052W High
597.40Open Price
560.00Prev. Close
424.7000Volume
250523.00Value
145378496.90Fundamentals
Market Cap
2333.10
Price to Earnings
-4.10
Price to Book Value
2.50
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
1325.71
Net Profit TTM
-567.39
Cash From Operating Activity
108.87
Return on Equity %
-60.76
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
59.1
Week
41.4
Month
44.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
572.50
PIVOT
First Resistance
592.80
Second Resistance
605.30
Third Resistance
625.60
First Support
560.00
Second Support
539.70
Third Support
527.20
Relative Strength Index
73.09
Money Flow Index
87.07
MACD
35.03
MACD Signal
21.37
Average True Range
27.31
Average Directional Index
30.69
Rate of Change (21)
46.78
Rate of Change (125)
50.19
Commodity Channel Index
116.8
Williams %R
-9.5
BETA
1 Month
0.92
3 Month
1.09
1 Year
0.92
3 Year
0.56
PRICE CHANGE ANALYSIS
↑ 6.5%
1 Week
Low
High
552.2
597.35
↑ 46.78%
1 Month
Low
High
390.95
597.35
↑ 51.84%
3 Months
Low
High
361.5
597.35
↑ 47.74%
6 Months
Low
High
322.52
597.35
↑ 58.21%
1 Year
Low
High
263.55
597.35
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 301.06 | 249.17 | 426.47 | 354.38 | 385.74 | 401.52 | 342.14 | 336.55 | 365.51 | 105.10 | 405.12 | |
| Operating Expenses Qtr | 289.63 | 410.40 | 387.57 | 333.17 | 329.07 | 349.46 | 310.85 | 320.39 | 347.88 | 196.96 | 329.44 | |
| Operating Profit Qtr | 9.80 | -161.67 | 37.67 | 19.14 | 51.55 | 45.29 | 27.52 | 9.68 | 12.94 | -96.62 | 72.17 | |
| EBIDT Qtr Cr | -111.89 | -224.00 | 35.35 | 21.21 | 56.67 | 52.06 | 31.29 | 16.16 | 16.32 | -93.38 | 75.60 | |
| Depreciation Qtr | 25.10 | 25.96 | 26.14 | 25.83 | 26.40 | 27.89 | 28.56 | 28.05 | 27.74 | 28.37 | 28.30 | |
| Net Profit Qtr | -256.40 | -275.33 | -15.26 | -19.88 | 6.46 | 0.42 | -9.91 | -19.18 | 0.22 | -139.57 | 30.23 | |
| Basic EPS Qtr | -71.23 | -76.49 | -4.24 | -5.52 | 1.79 | 0.12 | -2.75 | -5.33 | 0.06 | -38.85 | 8.42 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1294.29 | 1465.95 | 1287.10 | 1645.29 | 1349.26 | |
| Operating Expenses Annual Cr | 1383.98 | 1309.77 | 1187.99 | 1231.55 | 1065.22 | |
| Operating Profit Annual | -95.06 | 134.04 | 80.35 | 385.33 | 256.53 | |
| Operating Profit Margin Annual % | -7.34 | 9.14 | 6.24 | 23.42 | 19.01 | |
| Total Expenses Annual Cr | 1592.98 | 1510.73 | 1375.27 | 1424.33 | 1236.77 | |
| EBIDT Annual Cr | -89.69 | 156.18 | 99.11 | 413.74 | 284.04 | |
| EBIDT Annual margin % | -6.93 | 10.65 | 7.70 | 25.15 | 21.05 | |
| Depreciation | 103.03 | 110.90 | 112.01 | 108.31 | 93.67 | |
| PAT Before ExtraOrdinary Items Annual Cr | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 | |
| Net Profit Annual | -566.87 | -22.21 | -58.56 | 220.96 | 112.49 | |
| Basic EPS Annual | -157.48 | -6.17 | -16.29 | 68.86 | 43.47 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 937.42 | 1503.13 | 1527.05 | 1592.78 | 994.79 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 171.53 | 295.70 | 354.36 | 232.08 | 333.09 | |
| Total Current Liabilities Annual Cr | 1237.65 | 1096.12 | 1068.26 | 785.31 | 727.73 | |
| Total Capital Plus Liabilities Annual Cr | 2346.60 | 2894.95 | 2949.67 | 2610.17 | 2151.61 | |
| Fixed Assets Annual | 1517.46 | 1580.48 | 1572.80 | 1446.73 | 1414.30 | |
| Total Non Current Assets Annual | 1555.95 | 1704.08 | 1709.80 | 1552.18 | 1476.26 | |
| Total Current Assets Annual | 790.65 | 1190.87 | 1239.87 | 1057.99 | 675.35 | |
| Total Assets Annual | 2346.60 | 2894.95 | 2949.67 | 2610.17 | 2151.61 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 38.00 | 66.88 | 104.50 | 73.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 110.95 | 156.17 | -241.77 | 154.44 | 244.09 | |
| Cash from Investing Activity Annual | -4.66 | -81.13 | -243.08 | -105.25 | -358.81 | |
| Cash from Financing Annual Activity | -106.52 | -112.76 | 333.59 | 92.50 | 94.94 | |
| Net Cash Flow Annual | - | -37.72 | -151.26 | 141.69 | -19.78 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 260.39 | 417.54 | 424.18 | 443.42 | 370.50 | |
| ROE Annual % | -60.47 | -1.47 | -3.83 | 13.87 | 11.30 | |
| ROCE Annual % | -17.37 | 2.51 | -0.68 | 16.73 | 13.36 | |
| Total Debt to Total Equity Annual | 1.07 | 0.67 | 0.67 | 0.32 | 0.59 | |
| EBDIT Annual Margin % | -6.95 | 10.81 | 7.81 | 25.58 | 21.48 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 301.13 | 249.18 | 426.42 | 354.35 | 385.30 | 401.92 | 342.09 | 337.05 | 366.89 | 105.07 | 404.92 | |
| Operating Expenses Qtr | 289.67 | 410.42 | 387.61 | 333.19 | 331.85 | 349.75 | 310.80 | 317.52 | 347.29 | 197.18 | 329.75 | |
| Operating Profit Qtr | 9.76 | -161.69 | 37.63 | 19.12 | 48.77 | 45.00 | 27.57 | 12.55 | 13.53 | -96.84 | 71.86 | |
| EBIDT Qtr Cr | -110.72 | -224.01 | 33.59 | 21.16 | 53.45 | 52.17 | 31.29 | 19.53 | 18.29 | -93.63 | 75.09 | |
| Depreciation Qtr | 25.25 | 25.96 | 26.21 | 25.91 | 26.45 | 27.98 | 28.63 | 28.13 | 27.82 | 28.44 | 28.38 | |
| Net Profit Qtr | -255.34 | -275.34 | -17.16 | -19.55 | 3.77 | 0.45 | -9.96 | -16.43 | 1.88 | -139.87 | 29.71 | |
| Basic EPS Qtr | -70.93 | -76.49 | -4.77 | -5.43 | 1.05 | 0.12 | -2.77 | -4.56 | 0.53 | -38.93 | 8.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1294.29 | 1466.36 | 1288.36 | 1645.65 | 1349.27 | |
| Operating Expenses Annual Cr | 1384.10 | 1309.93 | 1188.37 | 1231.01 | 1062.31 | |
| Operating Profit Annual | -95.18 | 133.88 | 79.97 | 385.87 | 259.44 | |
| Operating Profit Margin Annual % | -7.35 | 9.13 | 6.21 | 23.45 | 19.23 | |
| Total Expenses Annual Cr | 1592.54 | 1511.18 | 1375.97 | 1424.15 | 1234.36 | |
| EBIDT Annual Cr | -89.81 | 156.43 | 99.99 | 414.64 | 286.96 | |
| EBIDT Annual margin % | -6.94 | 10.67 | 7.76 | 25.20 | 21.27 | |
| Depreciation | 103.33 | 111.19 | 112.32 | 108.66 | 94.16 | |
| PAT Before ExtraOrdinary Items Annual Cr | -566.96 | -22.25 | -58.29 | 221.35 | 114.52 | |
| Net Profit Annual | -567.39 | -22.18 | -58.15 | 221.40 | 114.61 | |
| Basic EPS Annual | -157.62 | -6.16 | -16.18 | 64.53 | 42.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 933.72 | 1500.21 | 1524.87 | 1588.52 | 989.94 | |
| Minority Interest Liability Annual Cr | 2.86 | 2.24 | 2.31 | 4.24 | 4.29 | |
| Total Non Current Liabilities Annual Cr | 171.53 | 295.70 | 354.36 | 232.07 | 333.38 | |
| Total Current Liabilities Annual Cr | 1242.85 | 1101.13 | 1070.99 | 788.75 | 729.89 | |
| Total Capital Plus Liabilities Annual Cr | 2350.96 | 2899.28 | 2952.53 | 2613.58 | 2153.50 | |
| Fixed Assets Annual | 1159.17 | 1237.34 | 1229.97 | 1104.47 | 1072.32 | |
| Total Non Current Assets Annual | 1550.21 | 1711.74 | 1713.25 | 1555.95 | 1481.51 | |
| Total Current Assets Annual | 800.75 | 1187.54 | 1239.28 | 1057.63 | 671.99 | |
| Total Assets Annual | 2350.96 | 2899.28 | 2952.53 | 2613.58 | 2153.50 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 38.00 | 66.88 | 104.50 | 73.51 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 108.87 | 156.25 | -242.03 | 155.46 | 244.22 | |
| Cash from Investing Activity Annual | -3.51 | -81.14 | -242.85 | -106.30 | -358.81 | |
| Cash from Financing Annual Activity | -105.65 | -112.76 | 333.57 | 92.49 | 94.91 | |
| Net Cash Flow Annual | - | -37.65 | -151.31 | 141.65 | -19.68 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 260.16 | 417.35 | 424.22 | 443.42 | 370.29 | |
| ROE Annual % | -60.76 | -1.47 | -3.81 | 13.93 | 11.57 | |
| ROCE Annual % | -17.42 | 2.51 | -0.65 | 16.76 | 13.54 | |
| Total Debt to Total Equity Annual | 1.07 | 0.67 | 0.67 | 0.32 | 0.59 | |
| EBDIT Annual Margin % | -6.96 | 10.83 | 7.88 | 25.64 | 21.71 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE FLEXI CAP FUND | 1.28 | 84848172 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ARUNKUMAR PILLAI | 3.48 | 84848145 | 100 | 0 |
| K R RAVISHANKAR | 2.76 | 84848146 | 0 | 0 |
| DEVICAM CAPITAL LLP | 15.55 | 84848159 | 0 | 0 |
| PRONOMZ VENTURES LLP | 4.86 | 84848160 | 65.22 | 0 |
| SRJR ENTERPRISE LLP | 3.54 | 84848161 | 88.23 | 0 |
| CHAYADEEP VENTURES LLP | 2.11 | 84848162 | 100 | 0 |
| AGNUS CAPITAL LLP | 1.77 | 84848163 | 72.34 | 0 |
| CHAYADEEP PROPERTIES PVT LTD | 1.1 | 84848164 | 100 | 0 |
| AGRAGANYA PRIVATE TRUST | 1.09 | 84848165 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE FLEXI CAP FUND | 1.28 | 84848172 |
| THE SCOTTISH ORIENTAL SMALLER COMPANIES TRUSTPLC | 2.92 | 84848182 |
| FSSA INDIAN SUBCONTINENT FUND AS SUB FUND OF FIRST SENTIER INVESTORS GLOBAL UMBRELLA FUND PLC | 2.4 | 84848177 |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC - FIRST SENTIER INVESTORS INTERNATIONAL IM LIMITED | 2.37 | 84848178 |
| HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD | 2.18 | 84848183 |
| ROUTE ONE OFFSHORE MASTER FUND, L.P. | 1.45 | 84848179 |
| TURNAROUND OPPORTUNITIES FUND | 1.06 | 84848174 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| SPIRACCA VENTURES LLP . | 7.79 | 84848185 |
| RAPTAKOS BRETT & CO LIMITED | 1.39 | 84848187 |
| TPG GROWTH IV SF PTE. LTD. | 8.6 | 84848192 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 18, 2021 | 3 | FINAL | - | Equity Share |
| Nov 19, 2020 | 4 | INTERIM | Nov 20, 2020 | Equity Share |
| Jul 28, 2020 | 2 | FINAL | - | Equity Share |
| Aug 06, 2019 | 5 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 29, 2024 | Audited Results | - |
| May 09, 2024 | To consider Fund Raising | - |
| Feb 14, 2024 | Quarterly Results | - |
| Nov 14, 2023 | Quarterly Results | - |
| Aug 14, 2023 | Quarterly Results | (Revised) |
| Jul 05, 2023 | Right issue of Equity Shares | - |
| May 12, 2023 | Audited Results | - |
| Jan 25, 2023 | Quarterly Results | - |
| Nov 09, 2022 | Quarterly Results | - |
| Aug 04, 2022 | Quarterly Results | - |
| Apr 29, 2022 | Audited Results & Dividend | - |
| Feb 09, 2022 | Quarterly Results | - |
| Nov 11, 2021 | Quarterly Results | - |
| Aug 04, 2021 | Quarterly Results | - |
| May 06, 2021 | Audited Results & Dividend | - |
| Feb 03, 2021 | Quarterly Results | - |
| Nov 11, 2020 | Interim Dividend | - |
| Oct 30, 2020 | Quarterly Results | - |
| Aug 03, 2020 | Quarterly Results | - |
| May 07, 2020 | Audited Results & Dividend | - |
| Feb 06, 2020 | Quarterly Results | - |
| Oct 22, 2019 | Quarterly Results | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 16, 2019 | Audited Results & Final Dividend | - |
| Jan 31, 2019 | Quarterly Results & Issue of Warrants | - |
| Jan 18, 2019 | Preferential Issue of shares | - |
| Oct 30, 2018 | Quarterly Results | - |
| Aug 03, 2018 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TPG Growth IV SF Pte Ltd
02 Jul 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for TPG Growth IV SF Pte Ltd
01 Jul 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Authum Investment & Infrastructure Ltd
28 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Closure of Trading Window
Closure of Trading Window for the quarter ended June 30, 2024
28 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Announcement Under Regulation 30 (LODR) - Grant Of ESOP
Grant of ESOP
24 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement
21 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Devicam Capital LLP
21 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Devicam Capital LLP
19 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 14, 2024 for Pronomz Ventures LLP
19 Jun 2024
Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 14, 2024 for Pronomz Ventures LLP
